UK HPA welcomes HCV diagnoses hike, but "still too many undiagnosed"
This article was originally published in Clinica
There has been a significant rise in new cases of hepatitis C virus (HCV) infection in England, but too many people remain unaware of being infected, the UK's Health Protection Agency (HPA) announced today. In 2008, almost 8,200 new cases were laboratory-reported, an increase of 6% year-on-year.
You may also be interested in...
Will FDA-cleared prescription digital therapeutics be able to follow wellness, chronic disease and sleep disorder apps onto the formularies of major payers? For digital therapeutics companies investing in randomized controlled clinical trials, GMP manufacturing and FDA submissions for products, the current absence of public health insurance coverage is frustrating.
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.
Biogen/Eisai’s US filing of aducanumab for Alzheimer’s has a ripple effect in China, where a leading biomedical researcher has publicly questioned data for the country’s first approved drug for the disease, GV971.